Buried in the body of this patent application from the prestigious Dr. Catriona Jamieson's lab is a "second" drug that can be used in combinations along with a long list of other drugs is our Imetelstat. HI may wish to comment and update any new IP (if there is any.) If I remember correctly Dr. Scarlett "promised" an update on the oral telomerase inhibitor development by the end of the year. Don't think we will see that update in 2022.
https://www.sumobrain.com/patents/wipo/ ... 398A1.html
Honorable mention (again)
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
-
Hoosier Investor
- Posts: 128
- Joined: Thu Jun 18, 2020 5:48 pm
Re: Honorable mention (again)
BP,
I’ve been watching Geron’s patent filings this year, but there haven’t been any new applications involving an oral formulation. I’ll advise if/when I see something on that topic.
I’ve been watching Geron’s patent filings this year, but there haven’t been any new applications involving an oral formulation. I’ll advise if/when I see something on that topic.
-
biopearl123
- Posts: 1670
- Joined: Fri Jul 20, 2018 5:13 pm
Re: Honorable mention (again)
Good to know, thanks HI.